Developmental Therapeutics

Gil G Mor MD, PhD, MSc

Professor of Obstetrics, Gynecology, and Reproductive Sciences; Division Director, Reproductive Sciences; Director Reproductive Immunology Unit and Discovery to Cure Program; Editor in Chief, AJRI

Departments & Organizations

Developmental Therapeutics

Obstetrics, Gynecology & Reproductive Sciences: Cancer Biology Group | Reproductive Immunology Group | Women's Reproductive Health Research Career Development Center

Developmental Therapeutics

Research Interests

Immunology of Gynecologic tumors; Immunology of Implantation; Ovarian Cancer Stem Cells more...


  • M.D., Hebrew University, 1987
  • M.Sc., Hebrew University of Jerusalem, 1988
  • Ph.D., Weizmann Institute of Science, 1993

Selected Publications

  • Steffensen KD, Alvero AB, Yang Y, Waldstrom M, Hui P, Holmberg JC, Silasi DA, Jakobsen A, Rutherford T, Mor G (2011) Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer. J Oncol. 2011:620523
  • Mor G, Yin G, Chefetz I, Yang Y, Alvero A (2011) Ovarian Cancer Stem Cells and Inflammation. Cancer Biol. Ther. April 15; 11(8):708-13.
  • Song J, Sapi E, Brown W, Nilsen J, Tartaro K, Kacinski BM, Craft J, Naftolin F, Mor G, Roles of Fas and Fas ligand during mammary gland remodeling, Journal of Clinical Investigation, 106(10):1209-20, November 2000 Abstract



Latest News


Edit Profile